Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. VGHCX: which is better?

Bottom line

XLV vs VGHCX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and VGHCX (Vanguard Health Care Fund) share a meaningful slice of their top holdings — about 53% by weight.

XLV is cheaper at 0.08% vs 0.33% — a difference of $25 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +6.6% for VGHCX.

Updated Nov 19, 2026

XLV vs VGHCX side by side

XLVVGHCX
TypeETFMutual fund
Fund familySPDR (State Street)Vanguard
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.33%
Annual cost per $10k$8$33
10-yr cost on $10k (prospectus)$103$418
Max front loadNone0%
12b-1 fee0.02%0%
1-yr return+14.5%+17.3%
5-yr return (annualized)+8.1%+6.6%
10-yr return (annualized)+9.8%+7.7%
Best quarter+14.5%+16.8%
Worst quarter−12.7%−12.3%
Net assets (fund)$40.6B$38.2B
Number of holdings6597
Portfolio turnover2%47%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVVGHCXDifference
2025+14.5%+17.3%−2.8%
2024+2.5%−1.6%+4.1%
2023+2.0%+5.4%−3.4%
2022−2.1%−1.1%−1.0%
2021+25.9%+14.3%+11.6%
2020+13.3%+12.6%+0.7%
2019+20.7%+22.9%−2.3%
2018+6.3%+1.2%+5.1%

Source: Fund prospectus bar charts

Holdings overlap

14 of XLV's top 25 holdings also appear in VGHCX's top 25.

Shared top holdings
HoldingXLVVGHCX
Eli Lilly & Co16.51%8.61%
Johnson & Johnson10.64%4.83%
AbbVie Inc7.74%2.30%
UnitedHealth Group Inc6.57%4.05%
Merck & Co Inc5.52%5.44%
Intuitive Surgical Inc2.45%2.52%
CVS Health Corp2.30%2.52%
Vertex Pharmaceuticals Inc2.19%2.36%
Danaher Corp2.09%2.18%
Elevance Health Inc1.46%1.83%
Boston Scientific Corp1.10%1.53%
Regeneron Pharmaceuticals Inc1.08%2.14%
HCA Healthcare Inc1.05%1.68%
Cencora Inc0.96%2.47%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

VGHCX top 10

  1. Eli Lilly & Co — 8.61%
  2. Merck & Co Inc — 5.44%
  3. Johnson & Johnson — 4.83%
  4. AstraZeneca PLC — 4.59%
  5. UnitedHealth Group Inc — 4.05%
  6. Gsk Plc — 3.00%
  7. Edwards Lifesciences Corp — 2.56%
  8. Intuitive Surgical Inc — 2.52%
  9. CVS Health Corp — 2.52%
  10. Cencora Inc — 2.47%

FAQ

What is the difference between XLV and VGHCX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and VGHCX (Vanguard Health Care Fund) share a meaningful slice of their top holdings — about 53% by weight. XLV is cheaper at 0.08% vs 0.33% — a difference of $25 a year per $10,000 invested.
Which is cheaper, XLV or VGHCX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and VGHCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.